Clinical Trials for Prostate Cancer

There are no clinicals trials found.


201308040

PARTIQoL: Prostate Advanced Radiation Technologies Investigating Quality of Life; A Phase III Randomized Clinical Trial of Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer Phase III Principal Investigator Michalski, Jeff Disease Site…

201410102

Positron emission tomography (PET) imaging of poly(ADP-ribose) polymerase (PARP) activity in cancer Phase Early Phase I Principal Investigator Dehdashti, Farrokh Disease Site Colon; Lip, Oral Cavity and Pharynx; Liver; No Disease; Pancreas; Rectum; Unknown Sites…

201411135

Tissue, Blood, and Urine Acquisition for Molecular and Cellular Analysis and Collection of Health Information for Patients with Malignancies of the Genitourinary Tract Phase N/A Principal Investigator Pachynski, Russell Disease Site Urinary Bladder

201703014

Phase II-III Trial Of Adjuvant Radiotherapy and Androgen Deprivation Following Radical Prostatectomy With or without Adjuvant Docetaxel Phase II/III Principal Investigator Michalski, Jeff Disease Site Prostate Learn more about this study at: clinicaltrials.gov

201703178

A Phase 2 Trial of Nivolumab Plus Ipilimumab, Ipilimumab Alone, or Cabazitaxel in Men with Metastatic Castration-Resistant Prostate Cancer Phase II Principal Investigator Pachynski, Russell Disease Site Prostate Learn more about this study at: clinicaltrials.gov

201704081

A Phase 3 Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer Phase III (Cancer Control) Principal Investigator Picus, Joel Disease Site Prostate Learn more about this study at: clinicaltrials.gov

201708148

A Randomized Phase II Trial of Abiraterone, Olaparib, or Abiraterone + Olaparib in Patients with Metastatic Castration-Resistant Prostate Cancer with DNA Repair Defects Phase II Principal Investigator Picus, Joel Disease Site Prostate Learn more about…

201712023

Phase III IGRT and SBRT vs IGRT and Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer Phase III Principal Investigator Michalski, Jeff Disease Site Prostate Learn more about this study at: clinicaltrials.gov

201712042

A Multicenter Study to Explore the Mechanism of Acquired Immune Escape in Patients with Metastatic Cancer Progressing on Checkpoint Inhibitor Therapy Phase IV Principal Investigator Pachynski, Russell Disease Site Anus; Bones and Joints; Brain and…

201801118

A phase I/II dose-escalation study evaluating the safety and efficacy of 21 Gy, 23 Gy, and 25 Gy for high dose rate (HDR) prostate brachytherapy Phase I/II Principal Investigator Gay, Hiram Disease Site Prostate Learn…

201808057

A Phase 2 Study of Ibrutinib as Neoadjuvant Therapy in Patients with Localized Prostate Cancer Phase II Principal Investigator Pachynski, Russell Disease Site Prostate Learn more about this study at: clinicaltrials.gov

201901059

Phase III Randomized Trial of Standard Systemic Therapy (SST) versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer Phase III Principal Investigator Baumann, Brian Disease Site…

201903057

A Prospective Comparative Study of Outcomes with Proton and Photon Radiation in Prostate Cancer (COMPPARE) Phase N/A Principal Investigator Michalski, Jeff Disease Site Prostate Learn more about this study at: clinicaltrials.gov

201903098

A multicenter, Randomized, controlled phase 2 study: Efficacy and safety of I-131-1095 Radiotherapy in combination with enzalutamide in metastatic castration-resistant prOstate cancer (mCRPC) patients Who are 18F-DCFPyL prostate-specific membrane antigen (PSMA)-avid, chemotherapy-naïve, and progressed on…

201903201

Randomized Phase II Trial of Salvage Radiotherapy with Standard vs Enhanced Androgen Deprivation Therapy (with Enzalutamide) in Patients with Post-Prostatectomy PSA Recurrences with Aggressive Disease Features Phase II Principal Investigator Gay, Hiram Disease Site Prostate…

201904214

IMPACT: Immunotherapy in Patients with Metastatic Cancers and CDK12 Mutations Phase II (Cancer Control) Principal Investigator Reimers, Melissa Disease Site Prostate Learn more about this study at: clinicaltrials.gov

201908024

A Pilot Study of Daily Imaging, Target Identification, and Simulated Computed Tomography-Based Stereotactic Adaptive Radiotherapy Workflow in a Novel Ring Gantry Radiotherapy Device Phase N/A Principal Investigator Henke, Lauren Disease Site Anus; Cervix; Colon; Corpus…

201908037

Randomized Phase II Trial of Niraparib with Standard Combination Radiotherapy and Androgen Deprivation Therapy (ADT) in High Risk Prostate Cancer (with Initial Phase I) Phase I/II Principal Investigator Baumann, Brian Disease Site Prostate Learn more…

202003164

RANDOMIZED PHASE III TRIAL INCORPORATING ABIRATERONE ACETATE WITH PREDNISONE AND APALUTAMIDE AND ADVANCED IMAGING INTO SALVAGE TREATMENT FOR PATIENTS WITH NODE-POSITIVE PROSTATE CANCER AFTER RADICAL PROSTATECTOMY Phase III Principal Investigator Baumann, Brian Disease Site Prostate…

202005108

Biologic tissue effect of sipuleucel-T on metastatic castration-resistant prostate cancer Phase N/A (Cancer Control) Principal Investigator Pachynski, Russell Disease Site Prostate

202006013

Phase II Trial of pTVG-HP DNA Vaccine with or without pTVG-AR DNA Vaccine and Pembrolizumab in Patients with Castration-Resistant, Metastatic Prostate Cancer Phase II Principal Investigator Pachynski, Russell Disease Site Metastatic Disease; Prostate Learn more…

202006062

A Phase I and Randomized Phase II Trial of Radium-223 Dichloride, M3814, & Avelumab in Advanced Metastatic Castrate-Resistant Prostate Cancer (mCRPC) – 10301 Phase I/II Principal Investigator Gay, Hiram Disease Site Prostate Learn more about…

202006147

TITLE PAGE A Phase II, Open-label, Study to Assess the Efficacy, Safety, and Tolerability of AZD4635 in Combination with Durvalumab and in Combination with Cabazitaxel and Durvalumab in Patients Who Have Progressive Metastatic Castrate-Resistant Prostate…

202007111

A Phase 1, Open-label Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of Oral EPI-7386 in Patients with Metastatic Castration-Resistant Prostate Cancer Phase I Principal Investigator Pachynski, Russell Disease Site Metastatic Disease; Prostate Learn…

202009082

A Phase 1b Clinical Trial of Cabozantinib and Abiraterone with Checkpoint Inhibitor Immunotherapy in Metastatic Hormone Sensitive Prostate Cancer (CABIOS Trial) Phase I Principal Investigator Pachynski, Russell Disease Site Prostate Learn more about this study…

202009203

A Phase 1 Study of FT-7051 in Men with Metastatic Castration-Resistant Prostate Cancer Phase I Principal Investigator Reimers, Melissa Disease Site Prostate Learn more about this study at: clinicaltrials.gov

202010193

INTREPId (INTermediate Risk Erection PreservatIon Trial): A Randomized Phase II Trial of Radiation Therapy and Darolutamide for Prostate Cancer Phase II Principal Investigator Michalski, Jeff Disease Site Prostate Learn more about this study at: clinicaltrials.gov

202101053

Parallel Phase III Randomized Trials For High Risk Prostate Cancer Evaluating De-Intensification For Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk with Radiation (Predict- RT*) *Prostate RNA Expression/Decipher To Individualize Concurrent…

202103038

Phase III Study of Local or Systemic Therapy INtensification DIrected in Prostate CAncer Patients with Post-ProstaTEctomy Biochemical Recurrence (INDICATE) Phase III Principal Investigator Gay, Hiram Disease Site Prostate Learn more about this study at: clinicaltrials.gov

202103170

SPLASH: Study Evaluating Metastatic Castrate Resistant ProstateCancer Treatment Using Lu-PNT2002 PSMA Therapy After Second-ilneHormonal Treatment Phase N/A Principal Investigator Michalski, Jeff Disease Site Prostate Learn more about this study at: clinicaltrials.gov